about
Intraprostatic Botulinum Toxin Type A injection in patients with benign prostatic enlargement: duration of the effect of a single treatment.Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamide.Botulinum toxin in the management of lower urinary tract dysfunction: contemporary update.Mini-arc for the treatment of female stress urinary incontinence: long-term prospective evaluation by patient reported outcomes.Suburethral single incision slings in the treatment of female stress urinary incontinence: what is the evidence for using them in 2010?Urinary neurotrophic factors in healthy individuals and patients with overactive bladder.Bladder pain induced by prolonged peripheral alpha 1A adrenoceptor stimulation involves the enhancement of transient receptor potential vanilloid 1 activity and an increase of urothelial adenosine triphosphate release.Distribution of the high-affinity binding site and intracellular target of botulinum toxin type A in the human bladder.Cumulative incidence and predictive factors of radiation cystitis in patients with localized prostate cancer.Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis.Urinary Neurotrophin Levels Increase in Women With Stress Urinary Incontinence After a Midurethral Sling Procedure.Exploratory study assessing efficacy and complications of TVT-O, TVT-Secur, and Mini-Arc: results at 12-month follow-up.Short-term assessment of a tension-free vaginal tape for treating female stress urinary incontinence.Ulcerative and nonulcerative forms of bladder pain syndrome/interstitial cystitis do not differ in symptom intensity or response to onabotulinum toxin A.Splenosis. A diagnosis to be considered.Metastatic castration-resistant prostate cancer and the challenge of a patient with chronic kidney disease in hemodialysis.The Role of Urinary Microbiota in Lower Urinary Tract Dysfunction: A Systematic ReviewAuthor ReplyBiomarkers in the Overactive Bladder Syndrome1677 INTRA-TRIGONAL INJECTION OF BOTULINUM TOXIN A IN PATIENTS WITH REFRACTORY BLADDER PAIN SYNDROME DECREASES URINARY NEUROTROPHINS AND IMPROVES LOWER URINARY TRACT SYMPTOMSHIGH AFFINITY BINDING SITES FOR BOTULINUM TOXIN TYPE A IN THE URINARY BLADDER: DISTRIBUTION AND NEUROCHEMISTRYDesensitization of bladder sensory fibers by intravesical capsaicin has long lasting clinical and urodynamic effects in patients with hyperactive or hypersensitive bladder dysfunctionExtra-adrenal phechromocytoma and renal cell carcinoma--an unusual case of tumour synchronismCurrent stepwise recommendations for hypogonadism screening in erectile dysfunction are not cost-effective
P50
Q33493614-CD58AA25-846A-4FE9-A22D-89CAE4C0E025Q34637448-C601A3B0-37F3-43FD-8E9B-B132AF40E75BQ35997057-7DE221C5-FE5C-456A-BEE6-6417C269440AQ37571029-1975F43D-99CF-48C3-9556-986C97022753Q37879343-3A31D907-EC28-44FD-86F8-87E1E93E407CQ39240698-DF9F5085-65B7-454F-9C99-320F7EAC613EQ40628033-DA134508-816B-4C9E-8B18-DB852C543036Q43203907-61C692F7-75D0-409B-AEEC-8068171D85BCQ47422689-9F7EC3BA-D399-42E0-8EB6-287350772BADQ48273100-C0922E81-3F99-4398-8DA6-12C18E5FAD68Q48489285-95E8DB86-7FC3-42DE-9633-D4CDB8FD0489Q51511125-5492CFE5-861E-453C-A045-E521F28B9DB9Q51662015-7469DCD9-FF05-43F6-AE03-4FAFCBA119F0Q53090822-D30963B9-5F7D-430D-A9E5-B29DFAA8E4B0Q53505743-A79C869C-07B8-4129-AECD-C8CF1BCA1448Q55287057-740B4F4E-72A2-44C5-8160-41F991446E76Q57068166-A5EB724D-3909-40F0-B764-DD7D2E126EDCQ59282521-87336227-097F-4231-9CFB-57288A6B3F2BQ59282592-BFDFF78B-1828-455A-80FB-6C65209DD6E4Q59282661-8BE18FBA-0F4D-4BC0-A7BA-723D98D231E1Q59282673-710BF919-DE5B-4D84-9C2B-6BD2F222FFC4Q71975861-C0E6C5B9-D420-45AE-B092-564C0B05CA41Q77848549-E694D6C8-A9EF-4C21-8F16-5E9F478FFA8BQ93053499-EE4A4C2F-ABF1-401B-BA51-966970A01D13
P50
description
onderzoeker
@nl
researcher ORCID: 0000-0002-1549-6833
@en
name
Carlos Silva
@ast
Carlos Silva
@en
Carlos Silva
@es
Carlos Silva
@nl
Carlos Silva
@sl
type
label
Carlos Silva
@ast
Carlos Silva
@en
Carlos Silva
@es
Carlos Silva
@nl
Carlos Silva
@sl
altLabel
Carlos Martins da Silva
@en
Carlos Martins-Silva
@en
Carlos da Silva
@en
prefLabel
Carlos Silva
@ast
Carlos Silva
@en
Carlos Silva
@es
Carlos Silva
@nl
Carlos Silva
@sl
P106
P1153
35077620700
35238822300
P21
P31
P496
0000-0002-1549-6833